rs2934971

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000578199.5(ERBB2):​c.-18+3073G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.66 in 151,310 control chromosomes in the GnomAD database, including 33,272 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.66 ( 33272 hom., cov: 28)

Consequence

ERBB2
ENST00000578199.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.49

Publications

18 publications found
Variant links:
Genes affected
ERBB2 (HGNC:3430): (erb-b2 receptor tyrosine kinase 2) This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized. [provided by RefSeq, Jul 2008]
ERBB2 Gene-Disease associations (from GenCC):
  • Hirschsprung disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • lung cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • glioma susceptibility 1
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • visceral neuropathy, familial, 2, autosomal recessive
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.714 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ERBB2NM_001289936.2 linkc.-23-1283G>T intron_variant Intron 4 of 30 NP_001276865.1
ERBB2NM_001005862.3 linkc.-18+3073G>T intron_variant Intron 4 of 29 NP_001005862.1
ERBB2NM_001382782.1 linkc.-18+3073G>T intron_variant Intron 4 of 29 NP_001369711.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ERBB2ENST00000578199.5 linkc.-18+3073G>T intron_variant Intron 4 of 17 1 ENSP00000462808.1
ERBB2ENST00000406381.6 linkc.-18+3073G>T intron_variant Intron 1 of 26 5 ENSP00000385185.2
ERBB2ENST00000584601.5 linkc.-68-1283G>T intron_variant Intron 4 of 30 2 ENSP00000462438.1

Frequencies

GnomAD3 genomes
AF:
0.660
AC:
99753
AN:
151192
Hom.:
33225
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.642
Gnomad AMI
AF:
0.793
Gnomad AMR
AF:
0.599
Gnomad ASJ
AF:
0.707
Gnomad EAS
AF:
0.400
Gnomad SAS
AF:
0.733
Gnomad FIN
AF:
0.710
Gnomad MID
AF:
0.709
Gnomad NFE
AF:
0.687
Gnomad OTH
AF:
0.653
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.660
AC:
99864
AN:
151310
Hom.:
33272
Cov.:
28
AF XY:
0.658
AC XY:
48655
AN XY:
73888
show subpopulations
African (AFR)
AF:
0.642
AC:
26457
AN:
41200
American (AMR)
AF:
0.600
AC:
9105
AN:
15184
Ashkenazi Jewish (ASJ)
AF:
0.707
AC:
2452
AN:
3466
East Asian (EAS)
AF:
0.400
AC:
2039
AN:
5096
South Asian (SAS)
AF:
0.734
AC:
3513
AN:
4784
European-Finnish (FIN)
AF:
0.710
AC:
7421
AN:
10446
Middle Eastern (MID)
AF:
0.697
AC:
205
AN:
294
European-Non Finnish (NFE)
AF:
0.687
AC:
46573
AN:
67824
Other (OTH)
AF:
0.654
AC:
1379
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1664
3327
4991
6654
8318
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
800
1600
2400
3200
4000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.664
Hom.:
10693
Bravo
AF:
0.646
Asia WGS
AF:
0.630
AC:
2169
AN:
3440

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.12
DANN
Benign
0.19
PhyloP100
-1.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2934971; hg19: chr17-37854507; COSMIC: COSV54079079; COSMIC: COSV54079079; API